Search results :

Emtricitabine

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: J05AF09

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Infection Infection 44% x x x x
Infection mixed postmarketing x x
Skin hyperpigmentation Skin hyperpigmentation postmarketing, 32% x x x x x x x
Cough Cough increased 28% x x x x x x
Otitis media Otitis media 23% x x x
Rhinitis Rhinitis 20% x x x x x x
Body temperature increased Body temperature increased postmarketing, 18% x x x x x
Pneumonia Pneumonia 15% x x x x
Diarrhoea Diarrhoea postmarketing — 5% - 20% x x x x x x x
Fasting Fasting 2% - 24% x x x x
Gastroenteritis Gastroenteritis 11% x x x
Abdominal pain Abdominal pain postmarketing — 10% x x x x x x x
Gastrointestinal pain Abdominal pain postmarketing — 10% x x x x x x x
Dermatitis Rash postmarketing — 9% - 21% x x x x x x x
Rash Rash postmarketing — 9% - 21% x x x x x x x
Asthenia Fatigue 8% x x x x
Asthenia postmarketing, common x x x x x x x
Fatigue Fatigue 8% x x x x
Anaemia Anaemia postmarketing — 7% - 9.5% x x x x x x x
Depression Depression 7% x x x x
Depressive disorder x x x x x
Dizziness Dizziness postmarketing — 7% x x x x x x x
Nausea Nausea postmarketing — 7% - 10% x x x x x x x
Insomnia Insomnia postmarketing — 7% x x x x x x x
Headache Headache postmarketing — 5% - 10.2% x x x x x x x
Hyperbilirubinaemia Hyperbilirubinaemia postmarketing, common x x
Upper respiratory tract infection Upper respiratory tract infection 5% x x x x
Vomiting Vomiting postmarketing — 5% - 23% x x x x x x x
Alanine aminotransferase increased Alanine aminotransferase increased postmarketing, common x x x
Sinusitis Sinusitis 4% x x x x
Nasopharyngitis Nasopharyngitis 3% x x x x
Dyspepsia Dyspepsia postmarketing, common x x x x x x x
Hypersensitivity Hypersensitivity postmarketing, common x x x x
Hypertriglyceridaemia Hypertriglyceridaemia postmarketing, common x x
Blood triglycerides increased Hypertriglyceridaemia postmarketing, common x x
Neutropenia Neutropenia postmarketing, common x x
Pain Pain postmarketing, common x x
Pruritus Pruritus postmarketing, common x x x x
Urticaria Urticaria postmarketing, common x x x x
Rash pustular Rash pustular postmarketing, common x x x x
Vesiculobullous rash postmarketing, common x x x x
Amylase increased Amylase increased postmarketing, common x x x
Dermatitis bullous Vesiculobullous rash postmarketing, common x x x x
Abnormal dreams Abnormal dreams postmarketing, common x x x x x x x
Rash maculo-papular Rash maculo-papular postmarketing, common x x x x
Haematuria Haematuria 2% - 3% x x x x x
Glycosuria Glycosuria 1% x x x x
Hyperglycaemia Hyperglycaemia postmarketing — 1% - 2% x x x x x x
Angioedema Angioedema postmarketing, uncommon x x
Lactic acidosis Lactic acidosis postmarketing x x x x x x
Autoimmune disorder Autoimmune disorder postmarketing x
Mental disorder Mental disorder postmarketing x x x x x x
Connective tissue disorder Connective tissue disorder postmarketing x x
Gastrointestinal disorder Gastrointestinal disorder postmarketing x x x x x x x
Basedow's disease Basedow's disease postmarketing x
Hepatitis Hepatitis postmarketing x x
Hepatomegaly Hepatomegaly postmarketing x x x x x
Hypercholesterolaemia Hypercholesterolaemia postmarketing x
Breast enlargement Hypertrophy of breast postmarketing x
Immune system disorder Immune system disorder postmarketing x x
Inflammation Inflammation postmarketing x x x
Insulin resistance Insulin resistance postmarketing x
Lipodystrophy acquired Lipodystrophy postmarketing x
Nervous system disorder Nervous system disorder postmarketing x x x x x x
Opportunistic infection Opportunistic infection postmarketing x
Osteonecrosis Osteonecrosis postmarketing x
Pancreatitis Pancreatitis postmarketing x x
Thrombocytopenia Thrombocytopenia postmarketing x
Skin discolouration Skin discolouration postmarketing — 31.8% x x x x x x x
Malnutrition Malnutrition postmarketing x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x
Renal impairment Function kidney decreased postmarketing x
Renal impairment postmarketing x
Hepatobiliary disease Hepatobiliary disease postmarketing x x
Lipohypertrophy Buffalo hump postmarketing x
Hyperlactacidaemia Hyperlactacidaemia postmarketing x
Renal failure Renal impairment postmarketing x
Renal failure x
Hepatic steatosis Hepatic steatosis postmarketing x x
Anxiety Anxiety x
Arthralgia Arthralgia x x x x x x
Musculoskeletal discomfort Arthralgia x x x x x x
Myalgia x x x x x x
Back pain Back pain x
Breast disorder Breast disorder x
Anogenital warts Anogenital warts x
Dysthymic disorder Depressive disorder x x x x x
Dyspnoea Dyspnoea x
Fanconi syndrome Fanconi syndrome x
Renal tubular disorder Fanconi syndrome x
Multiple fractures Fracture x
Fracture Fracture x
Hepatitis B Hepatitis B x x x x
Hypokalaemia Hypokalaemia x
Renal failure acute Renal failure acute x
Renal tubular necrosis Nephrosis lower nephron x
Mediastinal disorder Mediastinal disorder x
Myopathy Myopathy x
Tubulointerstitial nephritis Nephritis interstitial x
Neuritis Neuritis x x x x x x
Neuropathy peripheral Neuritis x x x x x x
Neuropathy peripheral x
Neuropathy x x x x x x
Osteomalacia Osteomalacia x
Paraesthesia Paraesthesia x x x x x x
Pharyngitis Pharyngitis x
Polyuria Polyuria x
Urine output increased Polyuria x
Proteinuria Proteinuria x
Protein urine present Proteinuria x
Prurigo Prurigo x
Rhabdomyolysis Rhabdomyolysis x
Syphilis Syphilis x
Urethritis Urethritis x
Urethritis noninfective Urethritis x
Urinary tract infection Urinary tract infection x
Urethral disorder Urinary tract disorder x
Urinary tract disorder Urinary tract disorder x
Weight decreased Weight decreased x
Hypophosphataemia Hypophosphataemia x
Secondary syphilis Secondary syphilis x
Genital ulceration Genital ulceration x
Blood creatine phosphokinase increased Creatine phosphokinase increased x x x
Blood creatinine increased Creatinine increased x
Blood creatinine increased x
Muscular weakness Muscular weakness x
Bone pain Bone pain x
Haemoglobin decreased Haemoglobin decreased x x x x
Nephrogenic diabetes insipidus Nephrogenic diabetes insipidus x
Rash macular Rash macular x
Rash vesicular Rash vesicular x
Myalgia Myalgia x x x x x x
Rash generalised Rash generalised x
Lipase increased Lipase increased x x x
Infestation Infestation NOS x x x x
Blood glucose decreased Glucose low x x x
Exfoliative rash Exfoliative rash x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

emtricitabine / emtricitabine

Side effects:55
Source:EMA

EMTRICITABINE / EMTRIVA

Side effects:36
Source:Health Canada

emtricitabine

Side effects:48
Source:FDA Structured Product Label

EMTRICITABINE

Side effects:50
Source:FDA Structured Product Label

emtricitabine / Emtriva

Side effects:59
Source:FDA

EMTRICITABINE

Side effects:85
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label